Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes

Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Venincasa VD, Kuriyan AE, Flynn Jr HW, Sridhar J, Miller D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07ba8412d4084b97a1b873f0b3a5f4a0
record_format dspace
spelling oai:doaj.org-article:07ba8412d4084b97a1b873f0b3a5f4a02021-12-02T03:01:42ZEndophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes1177-5483https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a02015-07-01T00:00:00Zhttp://www.dovepress.com/endophthalmitis-caused-by-pantoea-agglomerans-clinical-features-antibi-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outcomes associated with endophthalmitis caused by Pantoea agglomerans.Methods: A consecutive case series of patients with vitreous culture-positive endophthalmitis caused by P. agglomerans from January 1, 1990 to December 31, 2012 at a large university referral center. Findings from the current study were compared to prior published studies.Results: Of the three study patients that were identified, clinical settings included trauma (n=2) and post-cataract surgery (n=1). Presenting visual acuity was hand motion or worse in all three cases. All isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All isolates were resistant to ampicillin. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n=1) and pars plana vitrectomy with intravitreal antibiotic injection (n=2). At last follow-up, one patient had no light perception vision, while the other two had best-corrected visual acuity of 20/200 and 20/400.Conclusion: All Pantoea isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All patients in the current study received at least one intravitreal antibiotic to which P. agglomerans was shown to be sensitive in vitro. In spite of this, the visual outcomes were generally poor.Keywords: ocular infection, trauma, antibiotic resistanceVenincasa VDKuriyan AEFlynn Jr HWSridhar JMiller DDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1203-1207 (2015)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Venincasa VD
Kuriyan AE
Flynn Jr HW
Sridhar J
Miller D
Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
description Vincent D Venincasa, Ajay E Kuriyan, Harry W Flynn Jr, Jayanth Sridhar, Darlene Miller Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA Purpose: To report the clinical findings, antibiotic sensitivities, and visual outcomes associated with endophthalmitis caused by Pantoea agglomerans.Methods: A consecutive case series of patients with vitreous culture-positive endophthalmitis caused by P. agglomerans from January 1, 1990 to December 31, 2012 at a large university referral center. Findings from the current study were compared to prior published studies.Results: Of the three study patients that were identified, clinical settings included trauma (n=2) and post-cataract surgery (n=1). Presenting visual acuity was hand motion or worse in all three cases. All isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All isolates were resistant to ampicillin. Initial treatment strategies were vitreous tap and intravitreal antibiotic injection (n=1) and pars plana vitrectomy with intravitreal antibiotic injection (n=2). At last follow-up, one patient had no light perception vision, while the other two had best-corrected visual acuity of 20/200 and 20/400.Conclusion: All Pantoea isolates were sensitive to ceftazidime, gentamicin, imipenem, and fluoroquinolones. All patients in the current study received at least one intravitreal antibiotic to which P. agglomerans was shown to be sensitive in vitro. In spite of this, the visual outcomes were generally poor.Keywords: ocular infection, trauma, antibiotic resistance
format article
author Venincasa VD
Kuriyan AE
Flynn Jr HW
Sridhar J
Miller D
author_facet Venincasa VD
Kuriyan AE
Flynn Jr HW
Sridhar J
Miller D
author_sort Venincasa VD
title Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
title_short Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
title_full Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
title_fullStr Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
title_full_unstemmed Endophthalmitis caused by Pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
title_sort endophthalmitis caused by pantoea agglomerans: clinical features, antibiotic sensitivities, and outcomes
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/07ba8412d4084b97a1b873f0b3a5f4a0
work_keys_str_mv AT venincasavd endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes
AT kuriyanae endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes
AT flynnjrhw endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes
AT sridharj endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes
AT millerd endophthalmitiscausedbypantoeaagglomeransclinicalfeaturesantibioticsensitivitiesandoutcomes
_version_ 1718401961004367872